ARCHIVES

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concepts For Three New RFA Programs

July 6, 1984

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

NCI clinical trials cooperative group chairmen reject specimen bank contract proposal, endorse cooperative agreements;

January 2, 2004

Human Genome Project publishes its final product.

October 22, 2004

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

AC To Refuse Government Help In Future Projects

November 24, 1978